Philadelphia-based Fox Chase Cancer Center has been named a Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine & Molecular Imaging. Fox Chase is the first center in Philadelphia and one of three in Pennsylvania to receive the designation.

Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center had the lowest 30-day unplanned readmission rate of cancer hospitals exempt from reporting to Medicare's Inpatient Prospective Payment System.

The state of Wyoming had the lowest breast cancer screening rate in 2022 at 59.5% — nearly 20% lower than the state with the highest rate of 78.4%, Rhode Island.

Omaha, Neb.-based University of Nebraska Medical Center's Fred & Pamela Buffett Cancer Center has launched a new cancer prevention and control program to address cancer risk factors and population disparities specific to Nebraska. 

Effective Sept. 10, the FDA required healthcare facilities providing breast imaging services to notify patients of their breast density in mammography reports. Now, some experts are expressing concern over the new mandate, according to an Oct. 12 report from NBC News. 

The National Cancer Institute has launched a toolkit as part of its National Standards for Cancer Survivorship Care initiative to help health systems develop and improve survivorship care programs. 

Kansas City-based University of Kansas Cancer Center has launched the Center for Survivorship and Patient-Oriented Research as part of an initiative to improve not only cancer survival rates, but cancer survivor quality of life.

New York City-based NYU Langone has named Shridar Ganesan, MD, PhD, as director of the Perlmutter Cancer Center's new Center for Molecular Oncology. In collaboration with teams across NYU Langone, Dr. Ganesan will lead integration of genomic sequencing to personalize cancer care plans.

Houston-based University of Texas MD Anderson Cancer Center has partnered with the Union for International Cancer Control to address breast and cervical cancer on a global scale. 

Cancer survival among young adults has increased since the ACA's Dependent Care Expansion passed in 2010, allowing Americans to stay on their parents' health insurance plans until turning 26 years old, according to a study published Oct. 7 in Cancer. 

Los Angeles-based Cedars-Sinai is participating in the National Cancer Institute's first long-term national study of cancer among Asian Americans. Led by the University of California San Francisco, the study aims to learn why Asian Americans experience higher rates of cancer compared to other groups.

Advancements in immunotherapy and personalized medicine have pushed the oncology field forward, according to leaders from MD Anderson and City of Hope who shared their insights with Becker's.

Iowa City-based University of Iowa Health Care and Mission Cancer + Blood plan to partner in a $280 million deal to create a comprehensive cancer care network.

The U.S. spent $99 billion on both oral and clinician-administered cancer therapies in 2023, according to a report published in April by analytics firm IQVIA. As cancer drug prices continue to increase, spending is projected to grow.

Daniel Nikcevich, MD, saw a boat heading straight for him during a fishing trip in rural Minnesota. 

Rochester, Minn.-based Mayo Clinic has broken ground on a $9 million cancer center expansion at its New Prague, Minn., medical campus.

Along with the premarket approval of Siemens' 3D breast-imaging technology, the FDA  approved seven oncology and hematology drugs in September. 

Six U.S. health systems and cancer centers have joined the recently launched Together for Supportive Cancer Care consortium alongside more than 30 research institutions and advocacy groups with the aim to make supportive cancer care the standard of care.

Michel Sadelain, MD, PhD, a CAR-T therapy innovator and one of the world's top immunologists, has left New York City-based Memorial Sloan Kettering Cancer Center for two new roles at Columbia University Irving Medical Center, also in New York City.

From 2012 to 2021, breast cancer incidence has risen 1%, with steep increases among young women and Asian American/Pacific Islander women, according to the American Cancer Society.